The investigators reported the results of a prospective, randomized, phase 3 trial studying the best individual therapy for women who have node-negative, estrogen-receptor‒positive (ER-positive) ...

A review of the distribution of risk estimates from three commonly used genomic assays for breast cancer found that Black women were more likely to have aggressive tumor phenotypes, which contributed ...

* PRS313 predicts future breast cancer in women with ductal and lobular carcinoma * Women with higher// genetic risk face increased chances of recurrence * Family history further amplifies breast ...